TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23482644

Group type: EXPERIMENTAL
Intervention: MVA‐BN 10(7) TCID50
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MVA‐BN 10(8) TCID50
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 21525519

Group type: EXPERIMENTAL
Intervention: Lithium (0.25-0.5 mmol/l), n = 24
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo, n = 21
Number of subjects: 45
Study: 19252768

Group type: EXPERIMENTAL
Intervention: Periarterial infiltration of 3-5 ml of saline around scalp arteries
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Infiltration around only the superficial temporal arteries
Number of subjects: 40
Study: 17076867

Group type: EXPERIMENTAL
Intervention: Multifaceted education with CoaguChek device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multifaceted education without CoaguChek device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 15521369

Group type: EXPERIMENTAL
Intervention: 50 mg of rofecoxib
Number of subjects: 60

Group type: COMPARATOR
Intervention: Aspirin challenge
Number of subjects: 60
Study: 11220879

Group type: EXPERIMENTAL
Intervention: ST + losartan
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: ST + losartan + aldactone
Number of subjects: 91

Group type: COMPARATOR
Intervention: Standard therapy (ST)
Number of subjects: 91
Study: 9117826

Group type: EXPERIMENTAL
Intervention: Crab collagenase
Number of subjects: 21

Group type: COMPARATOR
Intervention: Trypsin/chymotrypsin
Number of subjects: 21
Study: 1492862

Group type: EXPERIMENTAL
Intervention: Dihydroergocristine (DHEC) 6 mg once daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 4023162

Group type: EXPERIMENTAL
Intervention: Estrogen-androgen combined preparation
Number of subjects: 53

Group type: COMPARATOR
Intervention: Estrogen-alone drug
Number of subjects: 53

Group type: COMPARATOR
Intervention: Androgen-alone drug
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 28705451

Group type: EXPERIMENTAL
Intervention: Nasal, noninhaled CO2 (n=19)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (n=13)
Number of subjects: 56
Study: 27755279

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) treatment
Number of subjects: 97

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) treatment after switch from TAU
Number of subjects: 97
Study: 25011544

Group type: EXPERIMENTAL
Intervention: REAC technology pulse (250 milliseconds)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 33
Study: 23683464

Group type: EXPERIMENTAL
Intervention: Bronchodilator response (BDR) test with a cutoff of 12%
Number of subjects: 1291

Group type: EXPERIMENTAL
Intervention: Bronchodilator response (BDR) test with a cutoff of less than 8%
Number of subjects: 1291
Study: 20949229

Group type: EXPERIMENTAL
Intervention: BiPAP (noninvasive ventilation)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard oxygen therapy (control group)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (BiPAP and standard oxygen therapy)
Number of subjects: 18
Study: 18571914

Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walking Test (ISWT) with supplementary oxygen
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Endurance Shuttle Walking Test (ESWT) with supplementary oxygen
Number of subjects: 41

Group type: COMPARATOR
Intervention: Incremental Shuttle Walking Test (ISWT) with air cylinder
Number of subjects: 41

Group type: COMPARATOR
Intervention: Endurance Shuttle Walking Test (ESWT) with air cylinder
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Comparison of percentage change between oxygen and air for responders
Number of subjects: 41
Study: 17011446

Group type: EXPERIMENTAL
Intervention: Continuous accelerated irradiation (CAIR) 7 days a week
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional 5 days a week (control)
Number of subjects: 100
Study: 12860355

Group type: EXPERIMENTAL
Intervention: 2‐repeat allele of the DRD4 exon III polymorphism
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: T,T genotype of the DRD4 ‐521 C>T polymorphism
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Gly9,Gly9 genotype of the DRD3 Ser9Gly polymorphism
Number of subjects: 145
Study: 10432885

Group type: EXPERIMENTAL
Intervention: Fine needle aspiration biopsy (FNAB)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Colonoscopy
Number of subjects: 32
Study: 7721604

Group type: EXPERIMENTAL
Intervention: Risk Factor Education (RFE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral Counseling (BC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral Counseling plus Incentives (BCI)
Number of subjects: 0
Study: 2383302

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (Kaveri)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6770498

Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis (oral nonabsorbed antibiotics)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parenteral administration of antibiotics
Number of subjects: 0
Study: 30957578

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) 600 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mefenamic acid 250 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of ALA and mefenamic acid
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 29074818

Group type: EXPERIMENTAL
Intervention: Sevelamer carbonate 4.8 g daily for 12 weeks
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 25254433

Group type: EXPERIMENTAL
Intervention: Counter-moralising messages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moralising messages
Number of subjects: 0
Study: 23577272

Group type: EXPERIMENTAL
Intervention: Anodal tDCS at 0.8 mA
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Anodal tDCS at 1.0 mA
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Anodal tDCS at 1.2 mA
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no tDCS)
Number of subjects: 14
Study: 22146249

Group type: EXPERIMENTAL
Intervention: Mandibular free-end removable partial dentures (RPDs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Not wearing RPDs
Number of subjects: 40

Group type: COMPARATOR
Intervention: Complete dentition
Number of subjects: 40
Study: 19860932

Group type: EXPERIMENTAL
Intervention: Dorsal Lithotomy (DL) position
Number of subjects: 98

Group type: COMPARATOR
Intervention: Dorsal Lithotomy with Same Side Leg Extended (DLEL) position
Number of subjects: 98
Study: 16498052

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF) - 0.5 g fat/kg body weight (BW) per day for 2.5 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: High-fat diet (HF) - 0.5 g fat/kg BW per day for 1 day followed by 3.5 g fat/kg BW per day for 1.5 days
Number of subjects: 11
Study: 15007562

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow injection (15 ml) at the fracture site and casting
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional casting
Number of subjects: 40
Study: 12495798

Group type: EXPERIMENTAL
Intervention: Naltrexone in a controlled drinking program (NTX+CD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Controlled drinking program alone (CD)
Number of subjects: 30
Study: 9836064

Group type: EXPERIMENTAL
Intervention: Panicogenic doses of caffeine administered to PD patients
Number of subjects: 19

Group type: COMPARATOR
Intervention: Panicogenic doses of caffeine administered to healthy volunteers
Number of subjects: 19
Study: 7659767

Group type: EXPERIMENTAL
Intervention: Nicotine gum (2-mg pieces, up to 30 per day) with reinforcement of lottery tickets for CO < 10 ppm
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Cigarette Self Report (CSR) with reinforcement for reporting no smoking that day
Number of subjects: 49

Group type: COMPARATOR
Intervention: Non-contingent payments (Control group)
Number of subjects: 49
Study: 2757892

Group type: EXPERIMENTAL
Intervention: Cromakalim (0.01‐10.0 micrograms min‐1)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cromakalim (0.001‐1.0 microgram min‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Glyceryl trinitrate (0.4 microgram min‐1)
Number of subjects: 8
Study: 1244406

Group type: EXPERIMENTAL
Intervention: Specific Training
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: General Training
Number of subjects: 40

Group type: COMPARATOR
Intervention: No Feedback Training
Number of subjects: 40

Group type: COMPARATOR
Intervention: No Training
Number of subjects: 40
Study: 6807878

Group type: EXPERIMENTAL
Intervention: 100 mg erythromycin ethyl succinate intramuscularly
Number of subjects: 30

Group type: COMPARATOR
Intervention: 500 mg erythromycin stearate orally
Number of subjects: 30
Study: 30885685

Group type: EXPERIMENTAL
Intervention: AG10 400 mg
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: AG10 800 mg
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 29935541

Group type: EXPERIMENTAL
Intervention: 5As eLearning program for obesity management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment as usual + training of the GP (intervention group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study: 26024926

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol‐electrolyte oral solution (PEG‐EOS)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Sodium picosulphate (SS)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Sodium biphosphonate (SP)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: PEG‐EOS with added flavour
Number of subjects: 313
Study: 25144598

Group type: EXPERIMENTAL
Intervention: Airflow (4.8 m/s) during exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Precooling (chest-deep immersion at 24 °C for 1 hour or until core temperature dropped 0.5 °C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No precooling or airflow (control)
Number of subjects: 10
Study: 23089439

Group type: EXPERIMENTAL
Intervention: Incision and drainage
Number of subjects: 64

Group type: COMPARATOR
Intervention: Needle aspiration
Number of subjects: 64
Study: 19879713

Group type: EXPERIMENTAL
Intervention: Low-strength medical compression stockings (MCS)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Traditional bandages
Number of subjects: 55
Study: 17391226

Group type: EXPERIMENTAL
Intervention: Suture-mediated vascular closure device
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual compression
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 15784495

Group type: EXPERIMENTAL
Intervention: Percutaneous radiologic gastrostomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nasogastric tube
Number of subjects: 60
Study: 12396159

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 70
Study: 10456303

Group type: EXPERIMENTAL
Intervention: Mouchel procedure
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Small slings
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Dacron
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Gore Tex
Number of subjects: 287
Study: 7872321

Group type: EXPERIMENTAL
Intervention: Chromagen (ferrous fumarate)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Feosol (ferrous sulfate)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Niferex (polysaccharide)
Number of subjects: 46
Study: 2193839

Group type: EXPERIMENTAL
Intervention: Frusemide/amiloride (20 mg frusemide/2.5 mg amiloride daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Bumetanide/potassium chloride (0.5 mg bumetanide/573 mg potassium chloride daily)
Number of subjects: 18
Study: 574221

Group type: EXPERIMENTAL
Intervention: Levodopa with benserazide
Number of subjects: 49

Group type: COMPARATOR
Intervention: Levodopa with carbidopa
Number of subjects: 49
Study: 30580092

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 15491

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 15491

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (clopidogrel and low-dose aspirin)
Number of subjects: 15491
Study: 28162017

Group type: EXPERIMENTAL
Intervention: Hand files
Number of subjects: 135

Group type: COMPARATOR
Intervention: ProTaper universal retreatment (PTUR) instruments
Number of subjects: 135

Group type: COMPARATOR
Intervention: Reciproc instruments
Number of subjects: 135
Study: 25834336

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-remifentanil (DR)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Propofol-remifentanil (PR)
Number of subjects: 59
Study: 24028650

Group type: EXPERIMENTAL
Intervention: Dietary intake assessment using a validated food-frequency questionnaire
Number of subjects: 4983

Group type: EXPERIMENTAL
Intervention: Multivariate linear regression analysis
Number of subjects: 4983

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 4983
Study: 22076086

Group type: EXPERIMENTAL
Intervention: 3 repetition maximum (3RM) back squats
Number of subjects: 9
Study: 19994684

Group type: EXPERIMENTAL
Intervention: Acupuncture and ginger-partition moxibustion
Number of subjects: 75

Group type: COMPARATOR
Intervention: Routine western medicine (Metoprolol, Propafenone, Aspirin)
Number of subjects: 75
Study: 17876009

Group type: EXPERIMENTAL
Intervention: Self-administered stress management training
Number of subjects: 310

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 310
Study: 15562063

Group type: EXPERIMENTAL
Intervention: Standard introduction to a Drager Fabius GS anesthesia delivery machine plus simulated clinical use of the new machine in a high-fidelity human patient simulator (HPS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard introduction alone
Number of subjects: 15
Study: 11727735

Group type: EXPERIMENTAL
Intervention: Trinam (1 x 10^11 viral particles, single administration)
Number of subjects: 210

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 210
Study: 9201495

Group type: EXPERIMENTAL
Intervention: Healthy, home-dwelling persons aged 65-70 years
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Oldest age groups (cataract operations)
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Oldest age groups (hip prosthesis operations)
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Oldest age groups (coronary by-pass operations)
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Patients with comorbidity and institutionalization
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Patients who smoke
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Elderly patients with moderate signs of dementia (cataract)
Number of subjects: 837
Study: 7506187

Group type: EXPERIMENTAL
Intervention: Nimesulide 800mg daily
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nimesulide 400mg daily
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nimesulide 600mg daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nimesulide 200mg daily
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nimesulide 300mg daily
Number of subjects: 16
Study: 2882234

Group type: EXPERIMENTAL
Intervention: Endotracheal adrenaline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Peripheral intravenous adrenaline
Number of subjects: 12
Study: 31626317

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 61

Group type: COMPARATOR
Intervention: No ART
Number of subjects: 61
Study: 28889834

Group type: EXPERIMENTAL
Intervention: ASA24-Kids-2014 dietary recalls
Number of subjects: 30

Group type: COMPARATOR
Intervention: Interviewer-administered dietary recalls
Number of subjects: 30
Study: 25310993

Group type: EXPERIMENTAL
Intervention: High dose Lupron Depot (22.5 mg leuprolide acetate)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Low dose Lupron Depot (11.25 mg leuprolide acetate)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 23452187

Group type: EXPERIMENTAL
Intervention: BCG induction therapy or BCG induction plus maintenance
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Maintenance BCG
Number of subjects: 971

Group type: COMPARATOR
Intervention: Intravesical chemotherapy
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: BCG maintenance therapy
Number of subjects: 971
Study: 21212378

Group type: EXPERIMENTAL
Intervention: Maximal exercise testing
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Submaximal exercise testing
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Maximal speed during treadmill test
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 6-minute walking distance
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Heart rate response, oxygen pulse, and OUES
Number of subjects: 23
Study: 17611132

Group type: EXPERIMENTAL
Intervention: Zafirlukast (40 mg orally the evening before and 40 mg the morning of assessment)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 16829089

Group type: EXPERIMENTAL
Intervention: On-pump surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Off-pump surgery
Number of subjects: 120
Study: 12883229

Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP) 1800 mg/d
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB) 1000 mg/d
Number of subjects: 63
Study: 10969365

Group type: EXPERIMENTAL
Intervention: Pre MB (morphine and bupivacaine)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pre M (morphine)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Post MB (morphine and bupivacaine)
Number of subjects: 80
Study: 8651747

Group type: EXPERIMENTAL
Intervention: Transfemoral placement of an endograft
Number of subjects: 17

Group type: COMPARATOR
Intervention: Open endoaneurysmorrhaphy
Number of subjects: 17
Study: 1451724

Group type: EXPERIMENTAL
Intervention: O-(beta-hydroxyethyl)-rutosides (HR) 2 x 1.5 g IV before surgery
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (untreated patients)
Number of subjects: 8
Study: 6396153

Group type: EXPERIMENTAL
Intervention: Single-dose oral co-trimoxazole
Number of subjects: 67

Group type: COMPARATOR
Intervention: Five-day oral co-trimoxazole
Number of subjects: 67
Study: 30807389

Group type: EXPERIMENTAL
Intervention: Microneedling followed by PMMA-collagen gel filler
Number of subjects: 44

Group type: COMPARATOR
Intervention: Microneedling alone
Number of subjects: 44
Study: 29994882

Group type: EXPERIMENTAL
Intervention: Blood pressure target of 72 mm Hg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Blood pressure target of 77 mm Hg
Number of subjects: 100
Study: 26197302

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: L-dopa
Number of subjects: 30
Study: 24386744

Group type: EXPERIMENTAL
Intervention: Breast/bottle feeding
Number of subjects: 192

Group type: COMPARATOR
Intervention: Spoon/syringe feeding
Number of subjects: 192
Study: 21318926

Group type: EXPERIMENTAL
Intervention: Affective message
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Cognitive message
Number of subjects: 580

Group type: COMPARATOR
Intervention: No-message control
Number of subjects: 580
Study: 19175510

Group type: EXPERIMENTAL
Intervention: Diet-plus-exercise interventions
Number of subjects: 18

Group type: COMPARATOR
Intervention: Diet-only interventions
Number of subjects: 18
Study: 17098529

Group type: EXPERIMENTAL
Intervention: Lower extremity vein bypass for CLI
Number of subjects: 1404
Study: 14751942

Group type: EXPERIMENTAL
Intervention: 80 rev/min during lower body exercise (LE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 40 rev/min during lower body exercise (LE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 40 rev/min during upper body exercise (UE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 60 rev/min during lower body exercise (LE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 60 rev/min during upper body exercise (UE)
Number of subjects: 24
Study: 11347286

Group type: EXPERIMENTAL
Intervention: Iscador
Number of subjects: 10226

Group type: COMPARATOR
Intervention: Control (no Iscador or mistletoe product)
Number of subjects: 10226

Group type: EXPERIMENTAL
Intervention: Iscador with good self-regulation
Number of subjects: 10226

Group type: EXPERIMENTAL
Intervention: Iscador with poor self-regulation
Number of subjects: 10226
Study: 8435171

Group type: EXPERIMENTAL
Intervention: Preoperative steroid treatment (methylprednisolone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative steroid treatment (methylprednisolone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SK&F 86002 (nonsteroidal dual cyclooxygenase/lipooxygenase inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed steroid administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative steroid therapy (in double-blinded placebo-controlled study)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 0
Study: 3304117

Group type: EXPERIMENTAL
Intervention: Verapamil (360 mg/24 h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/24 h)
Number of subjects: 0
Study: 30575794

Group type: EXPERIMENTAL
Intervention: Propolis extract (PPE) entrapped in niosomes
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 27062960

Group type: EXPERIMENTAL
Intervention: YOGA
Number of subjects: 26

Group type: COMPARATOR
Intervention: CON
Number of subjects: 26
Study: 26181217

Group type: EXPERIMENTAL
Intervention: Rapid response teams (intervention)
Number of subjects: 3135

Group type: COMPARATOR
Intervention: Delayed calls
Number of subjects: 3135
Study: 24013685

Group type: EXPERIMENTAL
Intervention: Baseline UPCR < 1.0 g/gCr
Number of subjects: 566

Group type: COMPARATOR
Intervention: Worsening UPCR (<0%) at 24 weeks
Number of subjects: 566

Group type: COMPARATOR
Intervention: Remission at 24 weeks
Number of subjects: 566

Group type: COMPARATOR
Intervention: Residual UPCR ≥ 1.0 g/gCr and ΔUPCR <30%
Number of subjects: 566
Study: 20805623

Group type: EXPERIMENTAL
Intervention: Low-dose unfractionated heparin, 50 U/kg
Number of subjects: 2026

Group type: COMPARATOR
Intervention: Standard-dose unfractionated heparin, 85 U/kg (60 U/kg with GpIIb‐IIIa inhibitors)
Number of subjects: 2026